European startup funding Q2 2013
Quarterly report · 2013-04-01 – 2013-06-30 · vs Q1 2013
Quarterly
Summary
auto-generatedIn Q2 2013, 470 rounds were recorded and disclosed equity funding (excluding debt and grants) reached €1.2B, up 57.6% versus Q1 2013. Debt rounds added a further €7.0M.
Deal count moved +16.3% versus Q1 2013, with 314 named investors participating.
Germany led by equity raised with €217M (18.2% of equity).
Healthtech was the most-funded sector at €244M in equity (20.5%).
The ten largest rounds accounted for 42.9% of disclosed capital, led by Ivey Business School's €158M.
22 exits were recorded this quarter worth a combined €2.0B.
Equity funding
€1.2B
▲ +57.6%excl. debt & grants · +€7.0M debt
Funding rounds
470
▲ +16.3%Companies funded
465
▲ +17.7%Named investors
314
▲ +16.3%Exits
22
▲ +4.8%Leading country
€217M
18.2% of equity
Leading sector
€244M
20.5% of equity
Provenance: 84% of 470 rounds disclosed an amount · 0% of priced rounds are high-confidence · EUR totals reconcile to ECB at-date within -14.64%
Methodology →Investments
Funding within Q2 2013
by monthFunding within Q2 2013 — interactive chart.
Data table
| Amount | Deals | |
|---|---|---|
| Apr | €518M | 149 |
| May | €309M | 146 |
| Jun | €640M | 175 |
Biggest deals
top 10 by amount- 1Ivey Business SchoolGrant · UK · Jun 2013€158M
- 2Biotie TherapiesGrant · Finland · Jun 2013€111M
- 3SupercellSeries B · Finland · Apr 2013€102M
- 4IconGrowth/Late · Germany · Jun 2013€46M
- 5SymphogenGrowth/Late · Denmark · May 2013€41M
- 6Auris MedicalSeries C · Switzerland · Apr 2013€40M
- 7UlmartOther · Russia · Jun 2013€38M
- 8OpsonaSeries C · Ireland · Apr 2013€33M
- 9GenSight BiologicsSeries A · France · Apr 2013€32M
- 10NumberFourSeries A · Germany · Jun 2013€29M
Concentration
top 10 deals42.9%
of disclosed capital came from the ten largest rounds.
Top 10 total
€630M
Period total
€1.5B
Countries
Top countries
equity raisedQ2 2013 — top countries — interactive chart.
Data table
| Q2 2013 — top countries | |
|---|---|
| Germany | €217M |
| UK | €180M |
| France | €158M |
| Finland | €130M |
| Israel | €80M |
| Switzerland | €76M |
| Spain | €76M |
| Ireland | €58M |
| Russia | €50M |
| Denmark | €44M |
Capital by country
share of equityQ2 2013 — capital by country — interactive chart.
Data table
| Q2 2013 — capital by country | |
|---|---|
| Germany | €217M |
| UK | €180M |
| France | €158M |
| Finland | €130M |
| Israel | €80M |
| Switzerland | €76M |
| Spain | €76M |
| Ireland | €58M |
| Russia | €50M |
| Denmark | €44M |
| Other | €119M |
Geographic distribution
European countries shown · click a countryQ2 2013 — geographic distribution — interactive chart.
Industries
Top sectors
equity raisedQ2 2013 — top sectors — interactive chart.
Data table
| Q2 2013 — top sectors | |
|---|---|
| Healthtech | €244M |
| Software | €186M |
| Gaming | €126M |
| Media | €116M |
| Consumer | €109M |
| Marketing | €109M |
| E-commerce | €77M |
| Fashion | €63M |
| Cybersecurity | €50M |
| Fintech | €47M |
Capital by sector
share of equityQ2 2013 — capital by sector — interactive chart.
Data table
| Q2 2013 — capital by sector | |
|---|---|
| Healthtech | €244M |
| Software | €186M |
| Gaming | €126M |
| Media | €116M |
| Consumer | €109M |
| Marketing | €109M |
| E-commerce | €77M |
| Fashion | €63M |
| Other | €367M |
Stages
Funding by stage
total euro raised by round typeQ2 2013 — funding by stage — interactive chart.
Data table
| Amount | |
|---|---|
| Seed | €93M |
| Series A | €307M |
| Series B | €239M |
| Series C | €155M |
| Series D+ | €34M |
| Early VC | €87M |
| Growth/Late | €160M |
| Debt | €7.0M |
| Grant | €272M |
| Crowdfunding | €0 |
| Other | €112M |
Exits
Exit activity
22
exits recorded
€2.0B
combined disclosed value
Exits breakdown
by typeQ2 2013 — exits by type — interactive chart.
Data table
| Q2 2013 — exits by type | |
|---|---|
| Acquisition | 17 |
| Buyout | 4 |
| IPO | 1 |